OBJECTIVES: Little research has investigated the demographic and symptom profile of medical cannabis users in states in the USA that have legalized cannabis use. METHODS: In the present cross-sectional study, we investigated the demographic profile of 217 adults currently receiving medical cannabis, as well as differences in problematic use and perceived helpfulness in terms of (i) symptoms of psychological disorders and pain, and (ii) motives for use. RESULTS: Findings indicated that medical cannabis users (i) use and perceive cannabis to be beneficial for multiple conditions, some for which cannabis is not specifically prescribed or allowed at the state level; and (ii) report similar rates of disordered use as compared with population estimates among regular users. Furthermore, problematic cannabis use was predicted by several symptoms of psychological disorders (e.g. depression) and a variety of use motives (e.g. coping), while cannabis was reported as particularly helpful among those with several psychological symptoms (e.g. traumatic intrusions), as well as those reporting use for social anxiety reasons. CONCLUSIONS: Results are discussed in terms of future directions for research given the current debates regarding legalization of cannabis for medical purposes and, more generally, the lack of empirical data to inform such debates.
OBJECTIVES: Little research has investigated the demographic and symptom profile of medical cannabis users in states in the USA that have legalized cannabis use. METHODS: In the present cross-sectional study, we investigated the demographic profile of 217 adults currently receiving medical cannabis, as well as differences in problematic use and perceived helpfulness in terms of (i) symptoms of psychological disorders and pain, and (ii) motives for use. RESULTS: Findings indicated that medical cannabis users (i) use and perceive cannabis to be beneficial for multiple conditions, some for which cannabis is not specifically prescribed or allowed at the state level; and (ii) report similar rates of disordered use as compared with population estimates among regular users. Furthermore, problematic cannabis use was predicted by several symptoms of psychological disorders (e.g. depression) and a variety of use motives (e.g. coping), while cannabis was reported as particularly helpful among those with several psychological symptoms (e.g. traumatic intrusions), as well as those reporting use for social anxiety reasons. CONCLUSIONS: Results are discussed in terms of future directions for research given the current debates regarding legalization of cannabis for medical purposes and, more generally, the lack of empirical data to inform such debates.
Authors: Brian E Perron; Kipling Bohnert; Angela K Perone; Marcel O Bonn-Miller; Mark Ilgen Journal: J Stud Alcohol Drugs Date: 2015-05 Impact factor: 2.582
Authors: Silvia S Martins; Christine M Mauro; Julian Santaella-Tenorio; June H Kim; Magdalena Cerda; Katherine M Keyes; Deborah S Hasin; Sandro Galea; Melanie Wall Journal: Drug Alcohol Depend Date: 2016-10-11 Impact factor: 4.492
Authors: Kipling M Bohnert; Brian E Perron; Lisham Ashrafioun; Felicia Kleinberg; Mary Jannausch; Mark A Ilgen Journal: Addict Behav Date: 2014-06-02 Impact factor: 3.913
Authors: Arthur Robin Williams; Mark Olfson; June H Kim; Silvia S Martins; Herbert D Kleber Journal: Health Aff (Millwood) Date: 2016-03 Impact factor: 6.301
Authors: Nalini Vadivelu; Alice M Kai; Gopal Kodumudi; Dan Haddad; Vijay Kodumudi; Niketh Kuruvilla; Alan David Kaye; Richard D Urman Journal: Curr Pain Headache Rep Date: 2018-03-19